Chronic cardiac insufficiency is a heart disease in which the heart cannot effectively pump blood to various parts of the body, resulting in insufficient blood supply to tissues and organs throughout the body. Chronic cardiac insufficiency is usually caused by myocardial damage or cardiac dysfunction caused by heart disease, which may lead to symptoms such as fatigue, difficulty breathing, lack of energy, and edema. APIs used clinically to treat chronic cardiac insufficiency include cardiotonic drugs such as digitalis, diuretics, and vasodilators such as nitroglycerin.
Protheragen-ING offers a full range of APIs for chronic cardiac insufficiency to support customer research worldwide.
Cat | Product Name | Cas | Details | Chemical Structure |
---|---|---|---|---|
API1350653201 | Vericiguat | 1350653-20-1 | View Details | |
API141505331 | Levosimendan | 141505-33-1 | View Details | |
API148849676 | lvabradine Hydrochloride | 148849-67-6 | View Details | |
API329635 | Racepinephrine/Adrenaline HCL | 329-63-5 | View Details | |
API49745951 | Dobutamine Hydrochloride | 49745-95-1 | View Details | |
API51423 | Epinephrine Bitartrate/Adrenaline Acid Tartrate | 51-42-3 | View Details | |
API87332 | Isosorbide Dinitrate | 87-33-2 | View Details | |
API922327 | Creatine phosphate disodium salt | 922-32-7 | View Details |
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed